Premium
Covista Inc (CVSA)
NYSE
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-10 | Mr. Stephen W. BeardCEO & Chairman | -5,29k | 690,20k | Automatic Disposition | 130,14 - 130,78 | 360,76k | -1,45% |
| 2026-05-18 | Mr. Manjunath GangadharanVP & CAO | -426,00 | 54,46k | Sale to Issuer | 127,85 | 3,10k | -12,08% |
| 2026-05-08 | Mr. Robert J. PhelanSenior VP & CFO | -10,00k | 1,26M | Vente | 126,21 | 45,85k | -17,91% |
| 2026-05-08 | Mr. Douglas G. BeckSenior VP of Institutional Support Services, General Counsel & Corporate Secretary | -9,62k | 1,22M | Vente | 127,03 | 32,76k | -22,69% |
| 2026-05-08 | Dr. Karen Sue CoxPresident of Chamberlain University | -2,00k | 249,00k | Vente | 124,50 | 28,17k | -6,63% |
| 2026-05-08 | Mr. Stephen W. BeardCEO & Chairman | -15,87k | 2,08M | Vente | 131,25 | 366,05k | -4,16% |
| 2026-04-15 | Mr. Scott Day LilesPresident of Adtalem Medical & Veterinary | -448,00 | 50,40k | Sale to Issuer | 112,49 | 7,40k | -5,71% |
| 2026-03-10 | Mr. Michael William MalafronteLead Independent Director | 36,04k | 3,64M | Achat | 100,86 - 100,94 | 138,60k | 35,14% |
| 2026-03-03 | Mr. Michael William MalafronteLead Independent Director | 1,20k | 117,56k | Achat | 97,97 | 101,12k | 1,20% |
| 2025-12-10 | Mr. Stephen W. BeardCEO & Chairman | -5,33k | 0,00 | Other Disposition | - | 381,93k | -1,38% |
| 2025-11-13 | Dr. Betty M. VandenboschIndependent Director | -421,00 | 40,53k | Sale to Issuer | 96,26 | 1,14k | -26,99% |
| 2025-11-13 | Ms. Lisa Warner WardellDirector | -645,00 | 62,09k | Sale to Issuer | 96,26 | 42,81k | -1,48% |
| 2025-11-13 | Mr. Evan TrentInitié | -355,00 | 34,17k | Sale to Issuer | 96,26 | 19,55k | -1,78% |
| 2025-11-13 | Mr. Robert J. PhelanSenior VP & CFO | -623,00 | 59,97k | Sale to Issuer | 96,26 | 55,85k | -1,10% |
| 2025-11-13 | Mr. Kenneth J. PhelanIndependent Director | -392,00 | 37,73k | Sale to Issuer | 96,26 | 18,39k | -2,09% |
| 2025-11-13 | Mr. Michael William MalafronteLead Independent Director | -526,00 | 50,63k | Sale to Issuer | 96,26 | 99,92k | -0,52% |
| 2025-11-13 | Mr. Scott Day LilesPresident of Adtalem Medical & Veterinary | -407,00 | 39,18k | Sale to Issuer | 96,26 | 6,75k | -5,69% |
| 2025-11-13 | Mr. William V. KrehbielIndependent Director | -421,00 | 40,53k | Sale to Issuer | 96,26 | 14,86k | -2,76% |
| 2025-11-13 | Ms. Georgette D. KiserIndependent Director | -425,00 | 40,91k | Sale to Issuer | 96,26 | 16,04k | -2,58% |
| 2025-11-13 | Ms. Donna J. HrinakIndependent Director | -344,00 | 33,11k | Sale to Issuer | 96,26 | 6,77k | -4,83% |
| 2025-11-13 | Mr. Maurice HerreraInitié | -343,00 | 33,02k | Sale to Issuer | 96,26 | 15,77k | -2,13% |
| 2025-11-13 | Mr. Manjunath GangadharanVP & CAO | -94,00 | 9,05k | Sale to Issuer | 96,26 | 2,15k | -4,19% |
| 2025-11-13 | Mr. Douglas G. BeckSenior VP of Institutional Support Services, General Counsel & Corporate Secretary | -361,00 | 34,75k | Sale to Issuer | 96,26 | 42,38k | -0,84% |
| 2025-11-13 | Dr. Karen Sue CoxPresident of Chamberlain University | -310,00 | 29,84k | Sale to Issuer | 96,26 | 30,17k | -1,02% |
| 2025-11-13 | Mr. William W. BurkeIndependent Director | -390,00 | 37,54k | Sale to Issuer | 96,26 | 8,98k | -4,16% |
| 2025-11-13 | Mr. Michael BetzChief Growth & Innovation Officer and President of Walden University | -441,00 | 42,45k | Sale to Issuer | 96,26 | 23,57k | -1,84% |
| 2025-11-13 | Mr. Stephen W. BeardCEO & Chairman | -9,20k | 885,98k | Sale to Issuer | 96,26 | 387,26k | -2,32% |
| 2025-11-10 | Mr. Robert J. PhelanSenior VP & CFO | -1,64k | 155,83k | Sale to Issuer | 95,19 | 62,17k | -2,57% |
| 2025-11-05 | Mr. Kenneth J. PhelanIndependent Director | 508,00 | 49,93k | Achat | 98,29 | 17,22k | 3,04% |
| 2025-11-04 | Mr. Michael William MalafronteLead Independent Director | 1 000,00 | 91,85k | Achat | 91,85 | 98,89k | 1,02% |
| 2025-09-08 | Mr. Stephen W. BeardCEO & Chairman | -12,94k | 1,76M | Sale to Issuer | 136,28 | 375,69k | -3,33% |
| 2025-08-28 | Ms. Lisa Warner WardellDirector | -25,48k | 3,37M | Vente | 132,38 | 41,89k | -37,82% |
| 2025-08-27 | Ms. Lisa Warner WardellDirector | -18,39k | 2,49M | Vente | 135,22 | 67,37k | -21,45% |
| 2025-08-25 | Ms. Lisa Warner WardellDirector | -5,16k | 697,90k | Sale to Issuer | 135,33 | 67,37k | -7,11% |
| 2025-08-23 | Mr. Evan TrentInitié | -9,30k | 1,25M | Sale to Issuer | 134,88 - 135,33 | 20,42k | -31,29% |
| 2025-08-23 | Mr. Robert J. PhelanSenior VP & CFO | -20,96k | 2,83M | Sale to Issuer | 134,88 - 135,33 | 63,81k | -24,72% |
| 2025-08-23 | Mr. Scott Day LilesPresident of Adtalem Medical & Veterinary | -2,78k | 375,51k | Sale to Issuer | 134,88 | 6,16k | -31,12% |
| 2025-08-23 | Ms. Sara HillSenior VP & Chief HR Officer | -1,00k | 135,28k | Sale to Issuer | 134,88 | 1,22k | -45,06% |
| 2025-08-23 | Mr. Maurice HerreraInitié | -11,07k | 1,49M | Sale to Issuer | 134,88 | 15,45k | -41,75% |
| 2025-08-27 | Mr. Manjunath GangadharanVP & CAO | -944,00 | 128,07k | Vente | 135,67 | 1,92k | -32,95% |
| 2025-08-23 | Mr. Manjunath GangadharanVP & CAO | -1,17k | 158,08k | Sale to Issuer | 134,88 | 1,92k | -37,89% |
| 2025-08-23 | Dr. Karen Sue CoxPresident of Chamberlain University | -10,11k | 1,36M | Sale to Issuer | 134,88 - 135,33 | 33,33k | -23,28% |
| 2025-08-23 | Mr. Douglas G. BeckSenior VP of Institutional Support Services, General Counsel & Corporate Secretary | -11,25k | 1,52M | Sale to Issuer | 134,88 - 135,33 | 41,94k | -21,15% |
| 2025-08-23 | Mr. Michael BetzChief Growth & Innovation Officer and President of Walden University | -11,46k | 1,55M | Sale to Issuer | 134,88 | 20,90k | -35,42% |
| 2025-08-23 | Mr. Stephen W. BeardCEO & Chairman | -138,85k | 18,73M | Sale to Issuer | 134,88 | 359,42k | -27,87% |
| 2025-08-21 | Ms. Lisa Warner WardellDirector | -12,90k | 1,71M | Vente | 132,90 | 80,63k | -13,79% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
